Abstract
Savoxepine-loaded poly(DL-lactic acid) (PLA) nanoparticles were prepared using an emulsion technique involving a salting-out process which avoids surfactants and chlorinated solvents. After their formation, the nanoparticles were purified by cross-flow microfiltration and subsequently freeze-dried. The drug loading and the drug entrapment efficacy were improved by using savoxepine base rather than the methanesulfonate salt and by modifying the pH of the aqueous phase. A drug entrapment efficacy as high as 95% was obtained with a 9% drug loading. The overall yield of the procedure can rise up to 93%. In vitro release studies have demonstrated that by varying the mean size of the nanoparticles and their drug loading, the release of the drug from the nanoparticles can be modulated to last from several hours to more than 30 days, thus allowing the preparation of an injectable extended-release dosage form.
Similar content being viewed by others
REFERENCES
C. Bindschaedler, R. Gurny, and E. Doelker. Osmotically controlled drug delivery systems produced from organic solutions and aqueous dispersions of cellulose acetate. J. Contr. Rel. 4:203–212 (1986).
F. Gumowski, E. Doelker, and R. Gurny. The use of a new redispersible aqueous enteric coating material. Pharm. Technol. 11 (2):26–32 (1987).
J. W. Vanderhoff and M. S. El-Aasser. Theory of colloids. In H. A. Liebermann, M. M. Rieger, and G. S. Banker (eds.), Pharmaceutical Dosage Forms: Disperse Systems, Marcel Dekker, New York, 1988, pp. 93–149.
R. Gurny, N. A. Peppas, D. D. Harrington, and G. S. Banker. Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Dev. Ind. Pharm. 7:1–25 (1981).
C. Vauthier-Holtzscherer, S. Benabbou, G. Spenlehauer, M. Veillard, and P. Couvreur. Methodology for the preparation of ultra-dispersed polymer systems. S.T.P. Pharma 1:109–116 (1991).
R. Gurny. Latex systems. In D. D. Breimer and P. Speiser (eds.), Topics in Pharmaceutical Science 1983, Elsevier, Amsterdam, 1983, pp. 277–288.
R. Gurny, T. Boye, and H. Ibrahim. Ocular theory with nano-particulates systems for controlled drug delivery. J. Contr. Rel. 2:353–361 (1985).
H. Ibrahim, C. Bindschaedler, E. Doelker, P. Buri, and R. Gurny. Concept and development of ophtalmic pseudo-latexes triggered by pH. Int. J. Pharm. 77:211–219 (1991).
R. C. Oppenheim. Solid colloidal drug delivery systems: nano-particles. Int. J. Pharm. 8:217–234 (1981).
J. W. Vanderhoff, M. S. El-Aasser, and J. Ugelstad. Polymer emulsification process. U.S. Patent 4,177,177 (1979).
H. Fessi, J. P. Devissaguet, F. Puisieux, and C. Thies. Procédé de préparation de systèmes colloïdaux dispersibles d'une substance, sous forme de nanoparticules. French Patent 2,608,988 (1986).
C. Bindschaedler, R. Gurny, and E. Doelker. Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powder and utilization thereof. U.S. Patent 4,968,350 (1990).
C. Bindschaedler, R. Gurny, and E. Doelker. Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powder and utilization thereof. European Patent 363549B1 (1993).
H. Ibrahim, C. Bindschaedler, E. Doelker, P. Buri, and R. Gurny. Aqueous nanodispersions prepared by a salting-out process. Int. J. Pharm. 87:239–246 (1992).
E. Allémann, R. Gurny, and E. Doelker. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process, influence of process parameters on particle size. Int. J. Pharm. 87:247–253 (1992).
E. Allémann, E. Doelker, and R. Gurny. Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process: Purification of an injectable dosage form. Eur. J. Pharm. Biopharm. 39:13–18 (1993).
C. Washington. Drug release from microdisperse systems: A critical review. Int. J. Pharm. 58:1–12 (1990).
M. Y. Levy and S. Benita. Drug release from submicrozed o/w emulsion: A new in vitro kinetic evaluation model. Int. J. Pharm. 66:29–37 (1990).
C. E. Matkovitch. Salting-out of acetone from water-basis of a new solvent extraction system. Anal. Chem. 45 (11):1915–1921 (1973).
J. Rabiant. La limitation des solvants résiduels. Aspect réglementaire. S.T.P. Pharma 1:278–283 (1991).
J. H. Finley. Spectrophotometric determination of polyvinylalcohol in paper coatings. Anal. Chem. 33:1925–1927 (1961).
B. Gander, R. Gurny, and E. Doelker. Einfluss der Zerfallseigenschaften von Tabletten auf die Freigabe und Absorption einer quasi unlöslischen Modellsubstanz. Acta Pharm. Technol. 31 (2):77–84 (1985).
B. Gander, K. Ventouras, R. Gurny, and E. Doelker. In vitro dissolution medium with supramicellar surfactant concentration and its relevance for in vivo absorption. Int. J. Pharm. 27:117–124 (1985).
L. Illum, M. A. Khan, E. Mak, and S. S. Davis. Evaluation of carrier capacity and release characteristics for poly(butyl 2-cyanoacrylate) nanoparticles. Int. J. Pharm. 30:17–28 (1986).
N. Ammoury, H. Fessi, J. P. Devissaguet, F. Puisieux, and S. Benita. In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules. J. Pharm. Sci. 79:763–767 (1990).
D. H. Lewis. Controlled release of bioactive agents from lactide/glycolide polymers. In M. Chasin and R. Langer (eds.), Biodegradable Polymers as Drug Delivery Systems, Marcel Dekker, New York, 1990, pp. 1–41.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Allémann, E., Leroux, JC., Gurny, R. et al. In Vitro Extended-Release Properties of Drug-Loaded Poly(DL-Lactic Acid) Nanoparticles Produced by a Salting-Out Procedure. Pharm Res 10, 1732–1737 (1993). https://doi.org/10.1023/A:1018970030327
Issue Date:
DOI: https://doi.org/10.1023/A:1018970030327